Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sofosbuvir with Ribavirin or Simeprevir in HCV GT4
NCT04385407Phase 2Completed
- Sponsor
- Beni Suef University
- Start
- Apr 2015
- Primary completion
- Jul 2016
- Modality
- Reversible Covalent Inhibitors, Allosteric Modulators, Orthosteric Ligands
01
Overview
A Phase 2 trial of sofosbuvir, simeprevir in hepatitis C virus infection, sponsored by Beni Suef University. Started Apr 2015; status: completed.
02
Drugs
sofosbuvirsimeprevir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NCT04385407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04385407.